Status:
COMPLETED
Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality
Lead Sponsor:
Danish Procalcitonin Study Group
Conditions:
Sepsis - to Reduce Mortality in the Intensive Care Unit
Eligibility:
All Genders
Brief Summary
Procalcitonin, a marker of infection has often been compared to clinical pictures as for instance "clinical sepsis". This has given som problems in the interpretation of these studies, because of the ...
Detailed Description
Sepsis is a major cause of mortality in the Intensive Care Unit (ICU). Efforts have been made to reduce the time needed to diagnose sepsis in order to reduce mortality from sepsis-related multi-organ ...
Eligibility Criteria
Inclusion
- Admitted to the ICU 4131 of Rigshospitalet Copenhagen University Hospital in the year 2002
- \-
Exclusion
- Recent (\< 3 months) liver transplantation
- Expected admission \< 24 h
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
End Date :
January 1 2003
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00144638
Start Date
January 1 2002
End Date
January 1 2003
Last Update
September 5 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. 4131, Rigshospitalet, Cph University Hosp., DK
Copenhagen, Denmark, DK-2100